文献速递肿瘤 PET/CT

前列腺特异性膜抗原(PSMA)靶向PET显像临床解读中的要点与陷阱

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-01

本文综述PSMA靶向PET显像在前列腺癌评估中的解读要点与技术及判读陷阱,强调需了解正常分布模式、放射性示踪剂摄取的生理变异及假阳性和假阴性来源;近年有多篇报告描述非前列腺良性或恶性病变在PSMA靶向PET上呈高摄取;了解这些局限可提高判读医师信心并改善患者照护。

要点

  • 判读PSMA靶向PET需熟悉正常分布模式与生理性摄取变异。
  • 需识别假阳性与假阴性来源,包括非前列腺良性或恶性病变的高摄取。
  • 了解技术及判读陷阱可提高判读医师信心并改善患者照护。

核心结论

  • PSMA靶向PET预计将在更大规模前瞻性试验中评估,传播潜在诊断陷阱及其生物学基础将愈发重要。

研究设计与样本

  • 综述,总结已发表文献中关于PSMA靶向PET显像的潜在要点及技术与判读陷阱。

主要发现

  • 近年有越来越多报告描述非前列腺良性或恶性病变在PSMA靶向PET显像上呈高摄取。

临床怎么用

  • 判读医师需了解正常分布模式、放射性示踪剂摄取的生理变异及假阳性和假阴性来源,以提高判读信心并改善患者照护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The rapidly expanding clinical adaptation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has placed an increasing onus on understanding both the potential pearls of interpretation as well as limitations of this new technique. As with any new molecular imaging modality, accurate characterization of abnormalities on PSMA-targeted PET imaging can be accomplished only if one is aware of the normal distribution pattern, physiological variants of radiotracer uptake, and potential sources of false-positive and false-negative imaging findings. In recent years, a growing number of reports have come to light describing incidental non-prostatic benign or malignant pathologies with high uptake on PSMA-targeted PET imaging. In this review, we have summarized the published literature regarding the potential pearls and technical and interpretive pitfalls of this imaging modality. Knowledge of these limitations can increase the confidence of interpreting physicians and thus improve patient care. CONCLUSIONS: As PSMA-targeted PET is expected to be evaluated in larger prospective trials, the dissemination of potential diagnostic pitfalls and the biologic underpinning of those findings will be of increased importance.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Sheikhbahaei S, Afshar-Oromieh A, Eiber M, et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. Eur J Nucl Med Mol Imaging. 2017. PMID: 28765998. doi:10.1007/s00259-017-3780-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。